Cohu to offer $200 million in convertible senior notes due 2031

Cohu, Inc. (COHU), a semiconductor equipment supplier, announced a private placement offering of $200 million in convertible senior notes due 2031 to qualified institutional buyers, leveraging its strong cash position to fund capped call transactions and general corporate purposes. This financing initiative follows a Q2 2025 earnings beat and significant product wins for its Eclipse and Neon platforms in next-gen processor and HBM/AI testing, though the stock, which gained nearly 40% in six months, recently declined amidst broader market concerns and an 'overvalued' assessment.

Analysis

Cohu, Inc. (COHU) is undertaking a strategic capital raise through a $200 million convertible senior note offering, leveraging a strong balance sheet characterized by a current ratio of 4.88 and a net cash position. The proceeds are designated for funding capped call transactions, a move aimed at mitigating shareholder dilution upon conversion, and for general corporate purposes. This financing occurs amidst a complex operational backdrop. On one hand, the company demonstrates positive momentum, having beaten Q2 2025 analyst expectations with an EPS of $0.02 and revenue of $107.7 million. Furthermore, significant design wins for its Eclipse and Neon platforms in next-generation processor and High Bandwidth Memory (HBM) testing position Cohu favorably within the high-growth AI and high-performance computing supply chains. On the other hand, several cautionary signals exist: the company's last-twelve-months EBITDA is negative at -$26.02 million, the stock is considered potentially overvalued after a nearly 40% gain over six months, and has recently declined on investor concerns about future guidance and market conditions.

Key Decisions for Investors

• Investors should weigh the company's strategic contract wins in high-growth segments like AI and HBM against its current valuation, which is flagged as potentially overvalued after its recent 40% appreciation.
• Monitor the final terms of the convertible note offering, specifically the conversion rate and premium, to accurately assess the potential for future share dilution and the company's effective cost of capital.
• Given the contrast between the positive Q2 earnings beat and the negative last-twelve-months EBITDA of -$26.02 million, it is prudent to scrutinize the company's forward guidance for a clearer picture of sustained profitability before committing new capital.